Effects of Fiberoptic Bronchoalveolar Lavage Combined with Azithromycin on Immune Function, Serum MCP-4, MAPK and CysLTR1 in Children with Mycoplasma Pneumoniae Pneumonia
ZHANG Juan, ZHAO Dongmei, TAN Qiong, et al. Effects of Fiberoptic Bronchoalveolar Lavage Combined with Azithromycin on Immune Function, Serum MCP-4, MAPK and CysLTR1 in Children with Mycoplasma Pneumoniae Pneumonia[J]. 2022,22(8):960-963.
ZHANG Juan, ZHAO Dongmei, TAN Qiong, et al. Effects of Fiberoptic Bronchoalveolar Lavage Combined with Azithromycin on Immune Function, Serum MCP-4, MAPK and CysLTR1 in Children with Mycoplasma Pneumoniae Pneumonia[J]. 2022,22(8):960-963. DOI: 10.14009/j.issn.1672-2124.2022.08.014.
OBJECTIVE: To probe into the treatment efficacy of fiberoptic bronchoalveolar lavage combined with azithromycin in children with Mycoplasma pneumoniae pneumonia. METHODS: A total of 130 children with M. pneumoniae pneumonia admitted into Nanchong Central Hospital from Oct. 2019 to Oct. 2021 were selected to be divided into the observation group and the control group via the random number table
with 65 cases in each group. The control group was treated with azithromycin
while the observation group received fiberoptic bronchoalveolar lavage combined with azithromycin. The clinical efficacy
treatment cost
pulmonary ventilation function indicators [tidal volume(TV)
vital capacity(VC)
total lung capacity(TLC) and maximal expiratory flow(MEF) ]
inflammatory factors [monocyte chemoattractant protein 4(McP-4)
mitogen-activated protein kinase(MAPK) and cysteine leukotriene receptor 1(CysLTR1)]
immune function indicators(CD3
+
CD4
+
CD8
+
and CD4
+
/CD8
+
)
treatment safety and other indicators were comprehensively evaluated in two groups. RESULTS: The total effective rate in the observation group was 92.31%(60/65)
higher than 78.46%(51/65) in the control group
with statistically significant difference(P
<
0.05). The treatment cost of the observation group was lower than that of the control group
the difference was statistically significant(P
<
0.05). After treatment
the levels of TV
VC
TLC and MEF in the observation group were higher than those in the control group
and the levels of MCP-4
MAPK and CysLTR1 were lower than those in the control group
with statistically significant difference(P
<
0.05). After treatment
the levels of CD3
+
CD4
+
and CD4
+
/CD8
+
in the observation group were higher than those in the control group
and the level of CD8
+
was lower than that in the control group
with statistically significant difference(P
<
0.05). During the treatment
the incidence of adverse drug reactions in the observation group and the control group was respectively 12.31%(8/65) and 9.23%(6/65)
and there was no significant difference between two groups(P
>
0.05). CONCLUSIONS: The treatment efficacy of fiberoptic bronchoalveolar lavage combined with azithromycin in the treatment of M. pneumoniae pneumonia is significant
which can improve the pulmonary ventilation function of children
inhibit the inflammatory response and improve the immune function with mild adverse drug reactions.
关键词
支原体肺炎阿奇霉素纤维支气管镜临床疗效肺通气功能炎症反应免疫功能
Keywords
Mycoplasma pneumoniae pneumoniaAzithromycinFiberoptic bronchoscopeClinical efficacyPulmonary ventilation functionInflammatory responseImmune function